medical decision support medical decision support
Sign In

Bournemouth Score of Mufti et al and Prognosis for the Myelodysplastic Syndromes

Description

The scoring system of Mufti et al for myelodysplasia uses hemoglobin, platelet count, neutrophil count and per cent bone marrow blasts to separate patients into prognostic groups and to predict likely survival time. The authors are from Royal Victoria Hospital in Bournemouth.


 

Parameters:

(1) hemoglobin in g/dL

(2) platelet count per µL

(3) percent blasts in the bone marrow

(4) absolute neutrophil count per µL

Parameter

Finding

Points

hemoglobin

> 10 g/dL

0

 

<= 10 g/dL

1

platelet count

> 100,000 /µL

0

 

<= 100,000 /µL

1

bone marrow blasts

< 5%

0

 

>= 5%

1

neutrophil count

> 2,500 /µL

0

 

<= 2,500 /µL

1

 

total score =

= (points for hemoglobin) + (points for platelet count) + (points for bone marrow blasts) + (points for neutrophil count)

 

Interpretation:

• minimum score: 0

• maximum score: 4

 

Score

Group

Median Survival

0-1

A

62 months

2-3

B

22 months

4

C

8.5 months

 


To read more or access our algorithms and calculators, please log in or register.

Specialty

ICD-10